BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7499738)

  • 21. Multiple congenital anomalies associated with apparently normal maternal intake of vitamin A: a phenocopy of the isotretinoin syndrome?
    Lungarotti MS; Marinelli D; Mariani T; Calabro A
    Am J Med Genet; 1987 Jun; 27(2):245-8. PubMed ID: 3474898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Troxidone (trimethadione) embryopathy: case report with reveiw of the literature.
    Rischbieth RH
    Clin Exp Neurol; 1979; 16():251-6. PubMed ID: 550945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Accutane--a new human teratogen as a cause of a new syndrome].
    Kucera J
    Cesk Pediatr; 1985 Jun; 40(6):358. PubMed ID: 3860303
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral isotretinoin: prescribers beware.
    Shear NH
    CMAJ; 1999 Jun; 160(12):1723-4. PubMed ID: 10410636
    [No Abstract]   [Full Text] [Related]  

  • 25. Isotretinoin teratogenicity. Case report with neuropathologic findings.
    Hansen LA; Pearl GS
    Acta Neuropathol; 1985; 65(3-4):335-7. PubMed ID: 3156465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype.
    Lopez-Rangel E; Van Allen MI
    Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):919-23. PubMed ID: 16265639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Birth defects caused by isotretinoin--New Jersey.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1988 Mar; 37(11):171-2, 177. PubMed ID: 3126387
    [No Abstract]   [Full Text] [Related]  

  • 28. Mycophenolate mofetil embryopathy: A newly recognized teratogenic syndrome.
    Perez-Aytes A; Marin-Reina P; Boso V; Ledo A; Carey JC; Vento M
    Eur J Med Genet; 2017 Jan; 60(1):16-21. PubMed ID: 27639443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple temporal bone anomalies in isotretinoin syndrome: a temporal bone histopathologic case report.
    Ishijima K; Sando I
    Arch Otolaryngol Head Neck Surg; 1999 Dec; 125(12):1385-8. PubMed ID: 10604421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital microtia in a neonate due to maternal isotretinoin exposure 1 month before pregnancy: Case Report.
    Shirazi M; Abbariki E; Pirjani R; Akhavan S; Dastgerdy E
    J Obstet Gynaecol Res; 2015 Jun; 41(6):975-8. PubMed ID: 25773513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antenatal Diagnosis of Fetal Retinoid Syndrome at 20 Weeks of Gestation: A Case Report.
    Erenel H; Ozel A; Oztunc F; Kizilkilic O; Comunoglu N; Uludag S; Madazli R
    Fetal Pediatr Pathol; 2018 Aug; 37(4):282-286. PubMed ID: 29843537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Embryopathy due to valproic acid with severe malformations in the central nervous system].
    Pardal-Fernández JM; Carrascosa-Romero MC; Rodríguez-Vázquez M; Marco-Giner J; Martínez-Gutiérrez A
    Rev Neurol; 2006 Mar 16-31; 42(6):336-40. PubMed ID: 16575769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neurobehavioral teratology of retinoids: a 50-year history.
    Adams J
    Birth Defects Res A Clin Mol Teratol; 2010 Oct; 88(10):895-905. PubMed ID: 20865785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Communication development of a young child with foetal retinoid syndrome: a seven-year follow-up study.
    Kritzinger A; Steenkamp L
    S Afr J Commun Disord; 2006; 53():39-48. PubMed ID: 20218489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Congenital heart disease in Southern Brazil: potential impact and prevention.
    da Silva JN; Trevisan P; Guimarães VB; Zen TD; da Rosa EB; Silveira DB; Varella-Garcia M; Paskulin GA; Rosa RF; Zen PR
    Int J Cardiol; 2015 Jan; 179():9-10. PubMed ID: 25464392
    [No Abstract]   [Full Text] [Related]  

  • 36. [Teratogenicity of isotretinoin].
    Dos Santos AM; Vaillant C; Pedespan JM; Fontan D; Guillard JM
    Arch Pediatr; 1998 Sep; 5(9):1046-7. PubMed ID: 9789644
    [No Abstract]   [Full Text] [Related]  

  • 37. Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.
    Brinker A; Kornegay C; Nourjah P
    Arch Dermatol; 2005 May; 141(5):563-9. PubMed ID: 15897377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital malformations of the external, middle, and inner ear produced by isotretinoin exposure in mouse embryos.
    Jarvis BL; Johnston MC; Sulik KK
    Otolaryngol Head Neck Surg; 1990 Apr; 102(4):391-401. PubMed ID: 2113267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isotretinoin and pregnancy.
    Stern RS; Rosa F; Baum C
    J Am Acad Dermatol; 1984 May; 10(5 Pt 1):851-4. PubMed ID: 6233342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continued occurrence of Accutane-exposed pregnancies.
    Honein MA; Paulozzi LJ; Erickson JD
    Teratology; 2001 Sep; 64(3):142-7. PubMed ID: 11514944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.